Theoretical, In Vitro Antiproliferative, and In Silico Molecular Docking and Pharmacokinetics Studies of Dehydrozingerone Mannich Base Heterocyclic Derivatives
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Senthil Kumar Raju und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Swamy Vivekanandha College of Pharmacy, Tiruchengode, Tamil Nadu, India. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Cell Proliferation, Antineoplastic Agents, Heterocyclic Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben.
Abstract (Originalsprache)
This study explores the design, synthesis, characterization, and pharmacological evaluation of chalcone‐derived C‐Mannich base compounds, which exhibit significant pharmacological potential in medicinal chemistry. A series of compounds 6 ( a – j ) was designed and investigated for the physicochemical properties, drug‐likeness, toxicity profile, and molecular interactions through in silico methods. Computational tools, including SwissADME online server and ProTox II web tool were utilized to assess their pharmacokinetics, druggability, and toxicity, while molecular docking investigations were performed with the ADT tools, AutoDock 4.2 software to ascertain the binding interactions of query molecules with critical protein targets, such as ESR1, ERBB2, PIK3CA, PIK3R1, EGFR, SRC, STAT3 and IGF1R. The selected compounds 6 ( a , c , e , i , and j ) were synthesized via a modified Mannich reaction utilizing dehydrozingerone (DHZ) along with 3‐hydroxy benzaldehyde and various secondary amines. The synthesized derivatives were characterized using the spectral and CHN elemental analysis. The in vitro antiproliferative potential of selected derivatives 6 ( a , c , e , i , and j ) was evaluated against the MCF‐7 (breast adenocarcinoma), A549 (Small cell lung carcinoma), HeLa (Cervical cancer), HeP2 (Colon cancer), HepG2 (Liver carcinoma) and NHDF (Normal Human Dermal Fibroplasts) the MTT assay using doxorubicin as standard. The study demonstrates that DHZ‐derived C‐Mannich base compounds possess significant anticancer efficacy, positioning them as promising candidates for subsequent therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Swamy Vivekanandha College of Pharmacy, Tiruchengode, Tamil Nadu, India.
- Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
- Department of Chemistry, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, India.
- Department of Chemistry, RTM Nagpur University, Nagpur, India.
- Natural Products and Medicinal Chemistry Division Indian Institute of Integrative Medicine, Jammu, India.
ORCID-Profile: Senthil Kumar Raju, Ajmal R Bhat
Zitieren
APA
Raju, S. K., Sekar, P., Sundhararajan, N., Alotaibi, B. S., Sankarganesh, M., Bhat, A. R., & Ahmed, S. (2025). Theoretical, In Vitro Antiproliferative, and In Silico Molecular Docking and Pharmacokinetics Studies of Dehydrozingerone Mannich Base Heterocyclic Derivatives. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70650
Vancouver
Raju SK, Sekar P, Sundhararajan N, Alotaibi BS, Sankarganesh M, Bhat AR, et al. Theoretical, In Vitro Antiproliferative, and In Silico Molecular Docking and Pharmacokinetics Studies of Dehydrozingerone Mannich Base Heterocyclic Derivatives. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70650
BibTeX
@article{Raju2025,
author = {Raju, Senthil Kumar and Sekar, Praveen and Sundhararajan, Naveena and Alotaibi, Badriyah Shadid and Sankarganesh, Murugesan and Bhat, Ajmal R and Ahmed, Sumeer},
title = {Theoretical, In Vitro Antiproliferative, and In Silico Molecular Docking and Pharmacokinetics Studies of Dehydrozingerone Mannich Base Heterocyclic Derivatives},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70650}
}
EUVIMED